Market Place
Sourcing Support
Bioasis braces to bite the dust as creditors circle
21 Jun 2023 //
FIERCE BIOTECH
Bioasis Provides Corporate Update & Announces Suspension of Operations
20 Jun 2023 //
GLOBENEWSWIRE
Bioasis Provides Update on Business Operations
23 Mar 2023 //
GLOBENEWSWIRE
Bioasis Announces AGM Results and Provides Update on Financial Position
03 Feb 2023 //
GLOBENEWSWIRE
Bioasis Announces Termination of Arrangement Agreement with Midatech Pharma plc
23 Jan 2023 //
GLOBENEWSWIRE
Bioasis Filing of Quarterly Financial Statements & MD&A for November 30, 2022
19 Jan 2023 //
GLOBENEWSWIRE
Bioasis Mails Information Circular for Annual Meeting of Securityholders
11 Jan 2023 //
GLOBENEWSWIRE
Midatech plots pivot beyond delivery tech with Bioasis buyout
20 Dec 2022 //
FIERCEPHARMA
Bioasis Announces Amendments to Arrangement Agreement with Midatech Pharma plc
19 Dec 2022 //
GLOBENEWSWIRE
Bioasis Technologies Inc. Announces Shareholder Webinar
14 Dec 2022 //
GLOBENEWSWIRE
Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc
13 Dec 2022 //
ACCESSWIRE
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
13 Dec 2022 //
GLOBENEWSWIRE
Bioasis Technologies Inc. Announces Stock Option Grants
08 Aug 2022 //
GLOBENEWSWIRE
Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A
29 Jul 2022 //
GLOBENEWSWIRE
Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets
16 Jun 2022 //
GLOBENEWSWIRE
Bioasis Announces Filing of Its Q4 and FY-End Financial Statements
14 Jun 2022 //
GLOBENEWSWIRE
Bioasis, Neuramedy sign blood-brain barrier pact for $72M
11 May 2022 //
FIERCEBIOTECH
Bioasis and Neuramedy Enter into Research Collaboration and License Agreement
10 May 2022 //
GLOBENEWSWIRE
J&J taps tiny Bioasis for tech to cross blood-brain barrier
20 Apr 2022 //
FIERCEPHARMA
Bioasis Enters Into Research Collaboration With Janssen
11 Apr 2022 //
GLOBENEWSWIRE
Bioasis to Attend and Present at Upcoming Industry Conference
09 Mar 2022 //
GLOBENEWSWIRE
Bioasis Announces $200,000 Non-Brokered Private Placement
17 Feb 2022 //
GLOBENEWSWIRE
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A
20 Jan 2022 //
GLOBENEWSWIRE
Bioasis to Attend and Present at Upcoming Industry Conferences
09 Dec 2021 //
GLOBENEWSWIRE
Bioasis Announces Annual General Meeting Details
29 Nov 2021 //
GLOBENEWSWIRE
Bioasis Announces the Appointment of Shadow Lake Group as Development Advisor
18 Aug 2021 //
GLOBENEWSWIRE
Bioasis Announces Allowance of Japanese Patent Application
09 Aug 2021 //
BIOSPACE
Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A
29 Jul 2021 //
GLOBENEWSWIRE
Bioasis Announces Positive Results From an Eff in a Model of Multiple Sclerosis
07 Jul 2021 //
GLOBENEWSWIRE
Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer
01 Jul 2021 //
GLOBENEWSWIRE
Bioasis Technologies and Oxyrane UK Ltd. enter into a Research Collaboration
30 Jun 2021 //
GLOBENEWSWIRE
Bioasis Technologies Announces Closing of Initial C$3,000,000 Funding
29 Jun 2021 //
GLOBENEWSWIRE
Bioasis Announces Filing of Its Q4 and Fiscal Year-End Financial Statements
25 Jun 2021 //
GLOBENEWSWIRE
Bioasis enters into Convertible Security Funding Agreement upto C$10 million
22 Jun 2021 //
GLOBENEWSWIRE
Bioasis Announces Publication Validating its xB³ ™ Platform Technology
03 Jun 2021 //
GLOBENEWSWIRE
